N
AMRX icon

Numerai’s Amneal Pharmaceuticals AMRX Stock Holding History

Numerai’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
77,906
-4,422
-5% -$60.6K 0.11% 320
2026
Q1 		$1.02M Sell
82,328
-42,613
-34% -$572K 0.1% 328
2025
Q4 		$1.57M Buy
124,941
+9,035
+8% +$103K 0.19% 160
2025
Q3 		$1.16M Sell
115,906
-210,969
-65% -$1.89M 0.16% 181
2025
Q2 		$2.64M Sell
326,875
-269,256
-45% -$2.03M 0.38% 83
2025
Q1 		$5M Buy
+596,131
New +$4.98M 0.94% 13

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Numerai's AMRX Position: Q2 2026 in Review

Numerai reduced its Amneal Pharmaceuticals (AMRX) stake by 5.4% in Q2 2026, selling an estimated $60.6K and leaving 77,906 shares worth $1.35M. The position accounts for 0.11% of the portfolio, ranked #320.

Numerai first reported a position in AMRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5M in Q1 2025. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Numerai held 77,906 shares of Amneal Pharmaceuticals worth $1.35M as of Q2 2026.
  • Numerai sold 4,422 Amneal Pharmaceuticals shares in Q2 2026, an estimated $60.6K.
  • Amneal Pharmaceuticals made up 0.11% of Numerai's portfolio in Q2 2026, its #320 holding.
  • Numerai first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Numerai's Amneal Pharmaceuticals position peaked at $5M in Q1 2025.
  • 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.